| Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study PA Waight, NJ Andrews, SN Ladhani, CL Sheppard, MPE Slack, E Miller The Lancet infectious diseases 15 (5), 535-543, 2015 | 705 | 2015 |
| Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study SN Ladhani, S Collins, A Djennad, CL Sheppard, R Borrow, NK Fry, ... The Lancet Infectious Diseases 18 (4), 441-451, 2018 | 559 | 2018 |
| Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries … AB Brueggemann, MJJ van Rensburg, D Shaw, ND McCarthy, KA Jolley, ... The Lancet Digital Health 3 (6), e360-e370, 2021 | 475 | 2021 |
| Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study S Flasche, AJ Van Hoek, E Sheasby, P Waight, N Andrews, C Sheppard, ... PLoS medicine 8 (4), e1001017, 2011 | 327 | 2011 |
| Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England AJ Van Hoek, CL Sheppard, NJ Andrews, PA Waight, MPE Slack, ... Vaccine 32 (34), 4349-4355, 2014 | 223 | 2014 |
| Whole genome sequencing of Streptococcus pneumoniae: development, evaluation and verification of targets for serogroup and serotype prediction using an automated pipeline G Kapatai, CL Sheppard, A Al-Shahib, DJ Litt, AP Underwood, ... PeerJ 4, e2477, 2016 | 159 | 2016 |
| Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia C Rodrigo, T Bewick, C Sheppard, S Greenwood, TM Mckeever, ... European Respiratory Journal 45 (6), 1632-1641, 2015 | 159 | 2015 |
| Impact of the coronavirus disease 2019 (COVID-19) pandemic on invasive pneumococcal disease and risk of pneumococcal coinfection with severe acute respiratory syndrome … Z Amin-Chowdhury, F Aiano, A Mensah, CL Sheppard, D Litt, NK Fry, ... Clinical infectious diseases 72 (5), e65-e75, 2021 | 150 | 2021 |
| MOST: a modified MLST typing tool based on short read sequencing R Tewolde, T Dallman, U Schaefer, CL Sheppard, P Ashton, B Pichon, ... PeerJ 4, e2308, 2016 | 133 | 2016 |
| Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England J Southern, N Andrews, P Sandu, CL Sheppard, PA Waight, NK Fry, ... PLoS One 13 (5), e0195799, 2018 | 122 | 2018 |
| Diagnosis of Streptococcus pneumoniae Infections in Adults with Bacteremia and Community-Acquired Pneumonia: Clinical Comparison of Pneumococcal PCR … MD Smith, CL Sheppard, A Hogan, TG Harrison, DAB Dance, ... Journal of clinical microbiology 47 (4), 1046-1049, 2009 | 112 | 2009 |
| Autolysin-targeted LightCycler assay including internal process control for detection of Streptococcus pneumoniae DNA in clinical samples CL Sheppard, TG Harrison, R Morris, A Hogan, RC George Journal of medical microbiology 53 (3), 189-195, 2004 | 101 | 2004 |
| Increased incidence of invasive pneumococcal disease among children after COVID-19 pandemic, England M Bertran, Z Amin-Chowdhury, CL Sheppard, S Eletu, DV Zamarreño, ... Emerging Infectious Diseases 28 (8), 1669, 2022 | 86 | 2022 |
| Real-time detection of Mycoplasma pneumoniae in respiratory samples with an internal processing control D Pitcher, VJ Chalker, C Sheppard, RC George, TG Harrison Journal of medical microbiology 55 (2), 149-155, 2006 | 81 | 2006 |
| Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: a case-control test-negative design study H Lawrence, H Pick, V Baskaran, P Daniel, C Rodrigo, D Ashton, ... PLoS medicine 17 (10), e1003326, 2020 | 75 | 2020 |
| Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS … D Shaw, R Abad, Z Amin-Chowdhury, A Bautista, D Bennett, K Broughton, ... The Lancet Digital Health 5 (9), e582-e593, 2023 | 73 | 2023 |
| Structural, genetic, and serological elucidation of Streptococcus pneumoniae serogroup 24 serotypes: discovery of a new serotype, 24C, with a variable capsule structure F Ganaie, K Maruhn, C Li, RJ Porambo, PL Elverdal, C Abeygunwardana, ... Journal of clinical microbiology 59 (7), 10.1128/jcm. 00540-21, 2021 | 71 | 2021 |
| Evolution of Streptococcus pneumoniae Serotype 3 in England and Wales: A Major Vaccine Evader N Groves, CL Sheppard, D Litt, S Rose, A Silva, N Njoku, S Rodrigues, ... Genes 10 (11), 845, 2019 | 70 | 2019 |
| Development of a sensitive, multiplexed immunoassay using xMAP beads for detection of serotype-specific Streptococcus pneumoniae antigen in urine samples CL Sheppard, TG Harrison, MD Smith, RC George Journal of medical microbiology 60 (1), 49-55, 2011 | 70 | 2011 |
| Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006–2018 N Andrews, A Kent, Z Amin-Chowdhury, C Sheppard, N Fry, M Ramsay, ... Vaccine 37 (32), 4491-4498, 2019 | 64 | 2019 |
